[Refractory cutaneous necrotizing vasculitis. Successful sulfone therapy]

Area of Science:

• Dermatology
• Immunology
• Rheumatology

Background:

• Cutaneous vasculitis presents with diverse clinical manifestations, ranging from mild symptoms to severe, multi-organ involvement.
• Chronic necrotizing vasculitis poses significant treatment challenges, often proving refractory to conventional immunosuppressive therapies.
• Established treatments like cyclophosphamide may fail in severe, long-standing cases of cutaneous vasculitis.

Observation:

• A case study details a patient with a 10-year history of severe cutaneous necrotizing vasculitis.
• The patient's condition did not improve despite adequate trials of various immunosuppressants, including cyclophosphamide.
• Treatment with diaminodiphenylsulfone (dapsone) resulted in complete remission of chronic vasculitic ulcerations.

Findings:

• Diaminodiphenylsulfone (dapsone) demonstrated significant efficacy in achieving complete remission of severe, chronic cutaneous necrotizing vasculitis.
• Dapsone offers a viable therapeutic option for refractory cases of inflammatory cutaneous diseases.
• Successful dapsone treatment highlights its potential in managing complex vasculitic conditions.

Implications:

• This case suggests dapsone as a promising treatment for severe, treatment-resistant cutaneous vasculitis.
• The findings may broaden the indications for dapsone in managing chronic inflammatory skin conditions.
• Further research into dapsone's mechanism and role in vasculitis is warranted for clinical practice guidelines.